Contraindications
Sensitivity to sulfonamides, severe renal or hepatic impairment, porphyria, SLE; infants <2 mth; pregnancy (3rd trimester), lactation.
|
Special Precautions
Renal insufficiency, elderly, blood dyscrasias, G6PD deficiency, AIDS.
|
Adverse Reactions
Nausea, vomitting, diarrhoea, hypersensitivity skin reaction, hypothyroidism, crystalluria, renal impairment , blood dyscrasias, kernicterus in premature neonates.
Potentially Fatal: Stevens-Johnson syndrome, agranulocytosis and aplastic anaemia. |
Drug Interactions
Concurrent use may increase phenytoin and methotrexate levels; increased risk of bleeding with warfarin and acenocoumarol; may potentiates antidiabetic effect of sulfonylureas.
Potentially Fatal: Increased risk of blood dyscrasias with clozapine and pyrimethamine. |
Lab Interference
Interference with tests for urea, creatinine, urinary glucose, urobilinogen.
|
Action
Description: Sulfamoxole interferes with nucleic acid synthesis in microorganisms by blocking the conversion of p-aminobenzoic acid to the coenzyme dihydrofolic acid.
|
MIMS Class
|